Advertisement
Amazon Lab Supplies
Amazon Lab Supplies

The Scientist

» drug development, microbiology and immunology

Most Recent

image: Infection-Autism Link Explained?

Infection-Autism Link Explained?

By | January 31, 2016

A mouse study suggests a mechanism by which severe infections during pregnancy increase autism risk. 

0 Comments

image: Cross-Reactive Ebola Antibodies

Cross-Reactive Ebola Antibodies

By | January 21, 2016

Human monoclonal antibodies induced during Ebola infection are able to neutralize related viral species, scientists show. 

0 Comments

image: Planning for the Next Ebola Outbreak

Planning for the Next Ebola Outbreak

By | January 20, 2016

A public-health nonprofit and an international drugmaker team up to stockpile hundreds of thousands of doses of a promising vaccine and to speed along the approval process.

0 Comments

image: Cord Blood Cells Foretell Food Allergy

Cord Blood Cells Foretell Food Allergy

By | January 13, 2016

Scientists link an immune phenotype present at birth to the development of food allergies a year later.

2 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Counting Cells

Counting Cells

By | January 11, 2016

A person likely carries the same number of human and microbial cells, according to a new estimate.

1 Comment

image: Molecular Fingerprint Predicts Flu Shot Response

Molecular Fingerprint Predicts Flu Shot Response

By | January 4, 2016

A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show. 

0 Comments

image: All Together Now

All Together Now

By | January 1, 2016

Understanding the biological roots of cooperation might help resolve some of the biggest scientific challenges we face.

1 Comment

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: The Age of Pharmabrewing

The Age of Pharmabrewing

By | January 1, 2016

We should not resist developing opiate-producing GM yeast for fear of the technology falling into the wrong hands.

0 Comments

Advertisement

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. Brain Keeps Watch During Sleep
  4. Locating Language within the Brain
Advertisement
LabX
LabX
Advertisement
LabX
LabX
RayBioTech
LI-COR Biosciences
LI-COR Biosciences